Trial Profile
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS).
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2012
Price :
$35
*
At a glance
- Drugs Tegaserod (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 19 Nov 2005 New trial record.